drugset / Trial / NCT00192855
Entacapone Augmentation for Schizophrenia
RandomizedFactorialDouble-blindTreatment
Summary
This study is testing the hypothesis that Entacapone added to ongoing antipsychotic treatment can be beneficial in schizophrenic patients with negative symptoms.
Timeline
- Start
- 2003-06
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entacapone | Small molecule | 600 mg | — |